Adolescents from 15 to 17 years old without comorbidity will be included in the COVID vaccination plan – El Financiero

The Government of Mexico announced this Tuesday that adolescents aged 15 to 17 years without comorbidity will be included in the National COVID Vaccination Plan.

Pre-registration will open next Friday, November 19, in the place mivacuna.salud.gob.mxsaid Hugo López-Gatell, Undersecretary of Health.

The authorities opened the registry for COVID vaccination to minors between 12 and 17 years old, but with comorbidities, in the first week of October. In this regard, the official commented that the vaccination units have received “very few people.”

“The estimate is over a million, less than 10 percent have approached the vaccination posts,” he stressed.

The official noted that, compared to other age groups, the mortality from COVID for this age group is reduced.

For example, in the age group 15 to 19 years, around 9,500 deaths were registered during 2020, according to data from the National Institute of Statistics and Geography cited by the undersecretary. Of these, López-Gatell added, only 249 were due to COVID-19.

“On the other hand, for other causes, from one to 6, there were 27 times more deaths from these causes than if we compared them with COVID,” he stressed.

‘Birthdays’ will be added to the COVID vaccination

López-Gatell also announced that another of the next steps in the National Vaccination Plan is that Mexicans who turn 18 in the course of 2022 receive one of the doses approved by the Federal Commission for the Protection against Sanitary Risks.

The undersecretary also called on pregnant women to inoculate not only against the SARS-CoV-2 virus, but also against the influenza virus.

See also  4 members of the body attacked by non-lung corona

“The COVID and influenza vaccines are safe,” he said.

What are comorbidities?

Comorbidity is the presence and coexistence of two or more diseases in the same person, some of them are heart conditions and other chronic diseases.

Here we tell you what are the diseases, illnesses and conditions in minors that will be worthy of the vaccine.

Chronic heart conditions
  • Congenital or acquired heart disease with evidence of heart failure
  • Primary or secondary hypertension in medical treatment with anti-hypertensive drugs.
Chronic lung disease
  • Poorly controlled severe asthma.

Use of high-dose inhaled steroids together with a second controller medication, in addition to at least one of the following: a) use of 3 or more cycles of systemic steroid in the previous year for asthma exacerbations, or b) one or more asthma hospitalizations in the previous year.

Patients with adequate inhaler-based control are not eligible in this group).

  • Ciliary dyskinesias.
  • Bronchopulmonary dysplasia.
  • Cystic fibrosis.
  • Interstitial pulmonary fibrosis.
  • Congenital malformations of the respiratory system.
Chronic disorders of the kidney, liver or digestive system
  • Congenital malformations of the kidney, liver or digestive system that are life-threatening.
  • Severe gastroesophageal reflux that can predispose to respiratory infections
  • Gastrostomy patients
  • Cirrhosis
  • Billiard Atresia
  • Chronic hepatitis
  • Chronic kidney failure grade 3 or higher including patient with replacement therapy (hemodialysis or peritoneal dialysis)
Chronic neurological disease
  • Neurodisability and / or neuromuscular disease including cerebral palsy, moderate or severe autism, hard-to-control epilepsy with neurological disease, and muscular dystrophy.
  • Congenital disorders that can affect the nervous system.
  • Hereditary and degenerative disease of the nervous system or muscles or other conditions associated with hypoventilation.
  • Multiple or severe or profound learning disabilities (PMLD).
  • Myasthenia and related diseases.
  • Multiple sclerosis
  • Down syndrome.
See also  Five New Caledonian patients treated with chloroquine
Endocrine diseases
  • Diabetes mellitus in any of its forms and degree of control.
  • Addison’s syndrome.
  • Hypopituitary syndrome.
  • Severe obesity (equal to or greater than 3 standard deviations (SD) from the 2007 WHO reference tables.
Moderate to severe immunosuppression
  • Active treatment for solid tumors or hematologic malignancies (leukemia, lymphoma, and myeloma), or within 3 years of healing.
  • Solid organ or stem cell transplant recipients within 2 years of transplantation or receiving immunosuppressive treatment).
  • On the waiting list for transplantation.
  • Moderate or severe primary immunodeficiency (for example: DiGeorge Syndrome, Wiskott Syndrome, Common Variable Immunodeficiency) or secondary to disease or treatment.
  • Active treatment with immunosuppressants that produce significant immunosuppression.
  • Autoimmune diseases that may require long-term immunosuppressive treatments, systemic lupus erythematosus and rheumatoid arthritis, among others.
  • HIV / AIDS infection.
  • Tuberculosis Infections.
Asplenia or spleen dysfunction and hematological diseases
  • Hereditary spherocytosis.
  • Homozygous sickle cell disease.
  • Thalassemia major.
  • Any other case of cause of asplenia.
  • Hemophilia
Serious genetic abnormalities affecting multiple systems
  • Mitochondrial diseases.
  • Chromosomal abnormalities.
  • Lysosomal diseases.
  • Inborn errors of metabolism
Teenage pregnancy
  • From nine weeks of pregnancy.


Leave a Comment